A phase I study of preoperative concomitant gemcitabine and external-beam radiation therapy and surgical resection for patients with extremity and trunk soft tissue sarcomas

Trial Profile

A phase I study of preoperative concomitant gemcitabine and external-beam radiation therapy and surgical resection for patients with extremity and trunk soft tissue sarcomas

Discontinued
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Gemcitabine (Primary)
  • Indications Soft tissue sarcoma
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Jul 2015 Results published in the Cancer.
    • 26 Mar 2015 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center.
    • 23 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top